S100 Biomarker in the Acute Management of Mild Head Injuries

Sponsor
Tampere University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02650765
Collaborator
Harvard Medical School (HMS and HSDM) (Other), Turku University Hospital (Other)
295
1
63
4.7

Study Details

Study Description

Brief Summary

A prospective validation study of the "Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults". Enrolling a consecutive sample of 1000 adult head injury patients from the emergency department of the Tampere University Hospital (Tampere, Finland). A venous blood sample with S100 analytics (+storage blood) is drawn from every patient. The patients are head CT-scanned according to the SNC guidelines. Outcome assessment (GOSE, MRS, Rivermead PCS Questionnaire) is completed as follows: 1 week, 6 months, 1 year, and 2 years.

Condition or Disease Intervention/Treatment Phase
  • Other: Indications for head CT imaging after acute head injury

Detailed Description

A prospective clinical head injury study conducted at the Emergency Department of the Tampere University Hospital, which is situated in Tampere, Finland. The hospital takes care of an catchment area of 524 447 inhabitants both from urban and rural areas. About 100 000 patients are treated in the Emergency department annually.

The study aims to improve the emergency evaluation of patients with an acute head injury, especially a mild head injury. About 80% of head CT scan performed on head injury patients in the Emergency Department of the Tampere University Hospital are negative (= no acute traumatic lesion). There is an urgent need to update the head CT imaging criteria/indications in the context of acute head injury in order to reduce the number of unnecessary scanning. More selective head CT indications result in considerable health care savings and decreased exposure to ionizing radiation, among other benefits.

In this study, the investigators implement the "Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults" criteria as part of the emergency care of adults head injury patients. By enrolling a large consecutive sample of patients the investigators are validating this new guideline. Emergency department assessment data is combined with long-term outcome parameters and blood-based biomarkers of neurotrauma.

The main aims of the study are:
  1. the validation of the Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults

  2. the examination of novel blood-based biomarkers of acute brain injury that correlate with the radiological severity of the injury and the long-term outcome

Study Design

Study Type:
Observational
Actual Enrollment :
295 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
S100 Biomarker in the Acute Management of Mild Head Injuries
Study Start Date :
Nov 1, 2015
Actual Primary Completion Date :
Feb 1, 2021
Actual Study Completion Date :
Feb 1, 2021

Outcome Measures

Primary Outcome Measures

  1. Non-contrast head CT [0-72h]

    Head CT findings: Intracranial traumatic lesions

Secondary Outcome Measures

  1. Glasgow Outcome Scale Extended [1 week, 6 months, 1 year, and 2 years]

    Glasgow Outcome Scale Extended

  2. Modified Rankin Scale [1 week, 6 months, 1 year, and 2 years]

    Modified Rankin Scale

  3. Rivermead PCS Questionnaire [1 week, 6 months, 1 year, and 2 years]

    Rivermead PCS Questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Head injury
Exclusion Criteria:
  • Age under 18 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tampere University Hospital Tampere Finland 33521

Sponsors and Collaborators

  • Tampere University Hospital
  • Harvard Medical School (HMS and HSDM)
  • Turku University Hospital

Investigators

  • Principal Investigator: Teemu M Luoto, MD, PhD, Tampere University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Teemu Luoto, MD, PhD, A/Prof, Tampere University Hospital
ClinicalTrials.gov Identifier:
NCT02650765
Other Study ID Numbers:
  • R15045
First Posted:
Jan 8, 2016
Last Update Posted:
Oct 6, 2021
Last Verified:
Oct 1, 2021
Keywords provided by Teemu Luoto, MD, PhD, A/Prof, Tampere University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 6, 2021